From mboxrd@z Thu Jan 1 00:00:00 1970 From: "Mildred Sharpe" Subject: {subj190107} Date: Fri, 19 Jan 2007 07:36:11 +0000 (UTC) Message-ID: <01c73b9c$aa286720$6c822ecf@actualsolemnized> Mime-Version: 1.0 Content-Type: text/plain; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable Return-path: Date: Fri, 19 Jan 2007 07:37:25 -0060 List-Unsubscribe: , List-Archive: List-Post: List-Help: List-Subscribe: , Sender: linux-pm-bounces@lists.osdl.org Errors-To: linux-pm-bounces@lists.osdl.org To: linux-pm@osdl.org List-Id: linux-pm@vger.kernel.org No more scam or shit companies. Look at charts and ask your adviser about: Ventana Medical Systems Ventana Receives FDA Approval on Pathway Thursday January 18, 10:08 am ET Ventana Medical Systems Receives FDA Approval for Breast Cancer Detection T= est TUCSON, Ariz. (AP) -- Ventana Medical Systems Inc., a maker of tissue and s= lide preparation systems used in drug development, said Wednesday it receiv= ed Food and Drug Administration approval on a new antibody. The company received the approval for its Pathway Her-2/neu (4B5) Rabbit Mo= noclonal Antibody as an aid in assessing breast cancer patients being consi= dered for treatment with Herceptin. It is also approved for use on the Vent= ana Image Analysis System. Herceptin is a cancer treatment made by Genentech Inc. It targets HER-2, wh= ich causes breast cancer cells to grow more rapidly. The approved Pathway a= ntibody is intended to detect the presence of the HER-2 antigen. Get in before most investors hear about this awesome news! VMSI has just m= ade an announcement which, once the investment community hears about it, is= going to send the issue flying! Read on to find why we are so excited!